Barry S. Orlek

1.1k total citations
38 papers, 881 citations indexed

About

Barry S. Orlek is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Barry S. Orlek has authored 38 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 20 papers in Organic Chemistry and 6 papers in Pharmacology. Recurrent topics in Barry S. Orlek's work include Chemical Synthesis and Analysis (12 papers), Receptor Mechanisms and Signaling (9 papers) and Antibiotic Resistance in Bacteria (5 papers). Barry S. Orlek is often cited by papers focused on Chemical Synthesis and Analysis (12 papers), Receptor Mechanisms and Signaling (9 papers) and Antibiotic Resistance in Bacteria (5 papers). Barry S. Orlek collaborates with scholars based in United Kingdom, United States and South Africa. Barry S. Orlek's co-authors include Peter G. Sammes, V Knott-Hunziker, Graham J. Riley, Stephen G. Waley, Frank Brown, Harry J. Wadsworth, Michael Clark, Paul Wyman, Julie A. Hawkins and Michael S. Hadley and has published in prestigious journals such as Biochemical Journal, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Barry S. Orlek

38 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry S. Orlek United Kingdom 15 459 430 181 138 84 38 881
Jordan Hirshfield United States 15 525 1.1× 428 1.0× 86 0.5× 219 1.6× 64 0.8× 24 957
P. H. BENTLEY United Kingdom 13 285 0.6× 291 0.7× 105 0.6× 189 1.4× 74 0.9× 33 807
Barton J. Bradbury United States 15 257 0.6× 323 0.8× 130 0.7× 118 0.9× 30 0.4× 20 600
Gregory S. Welmaker United States 15 359 0.8× 478 1.1× 46 0.3× 128 0.9× 63 0.8× 20 894
R. A. DAINES United States 14 598 1.3× 363 0.8× 53 0.3× 247 1.8× 52 0.6× 25 961
Guo‐Hua Chu United States 13 236 0.5× 295 0.7× 180 1.0× 124 0.9× 64 0.8× 28 627
Yushe Yang China 19 563 1.2× 389 0.9× 85 0.5× 181 1.3× 47 0.6× 64 1.0k
John M. Berge United Kingdom 18 418 0.9× 543 1.3× 39 0.2× 90 0.7× 97 1.2× 29 977
G. B. MULLEN United States 14 445 1.0× 372 0.9× 45 0.2× 55 0.4× 54 0.6× 59 734
Troy Wymore United States 17 129 0.3× 423 1.0× 77 0.4× 100 0.7× 41 0.5× 47 728

Countries citing papers authored by Barry S. Orlek

Since Specialization
Citations

This map shows the geographic impact of Barry S. Orlek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry S. Orlek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry S. Orlek more than expected).

Fields of papers citing papers by Barry S. Orlek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry S. Orlek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry S. Orlek. The network helps show where Barry S. Orlek may publish in the future.

Co-authorship network of co-authors of Barry S. Orlek

This figure shows the co-authorship network connecting the top 25 collaborators of Barry S. Orlek. A scholar is included among the top collaborators of Barry S. Orlek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry S. Orlek. Barry S. Orlek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bailey, James, Gordon Bruton, Anthony Huxley, et al.. (2009). A Practical Synthesis of Differentially Protected 4,4′-Dipiperidinyl Ethers: Novel Ligands of Pharmaceutical Interest. Synlett. 2009(7). 1051–1054. 3 indexed citations
2.
Bruton, Gordon, Anthony Huxley, Peter J. O’Hanlon, et al.. (2003). Lipopeptide substrates for SpsB, the Staphylococcus aureus type I signal peptidase: design, conformation and conversion to α-ketoamide inhibitors. European Journal of Medicinal Chemistry. 38(4). 351–356. 47 indexed citations
3.
Campbell, Colin A., Frank C. Barone, Christopher D. Benham, et al.. (2000). Characterisation of SB-221420-A — a neuronal Ca2+ and Na+ channel antagonist in experimental models of stroke. European Journal of Pharmacology. 401(3). 419–428. 12 indexed citations
4.
Chan, Wai N., Michael S. Hadley, John D. Harling, et al.. (2000). Evaluation of a Series of Anticonvulsant 1,2,3,4-Tetrahydroisoquinolinyl-benzamides. Bioorganic & Medicinal Chemistry. 8(8). 2085–2094. 8 indexed citations
5.
Doughty, Stephen W., Frank E. Blaney, Barry S. Orlek, & W. Graham Richards. (1998). A molecular mechanism for toxin block in N-type calcium channels. Protein Engineering Design and Selection. 11(2). 95–99. 11 indexed citations
6.
Chan, Wai N., Michael S. Hadley, John D. Harling, et al.. (1998). Identification of a series of 1,2,3,4-tetrahydroisoquinolinyl- benzamides with potential anticonvulsant activity. Bioorganic & Medicinal Chemistry Letters. 8(20). 2903–2906. 12 indexed citations
7.
8.
Orlek, Barry S., et al.. (1997). Stereoselective construction of vicinal diamines. Part 3.1 Routes to the benz[ f ]indeno[1,7-bc] azepine and benz[e]indeno[2,1-b][1,4]diazepine ring systems. Journal of the Chemical Society Perkin Transactions 1. 2775–2778. 1 indexed citations
9.
Bromidge, Steven M., Frederick Cassidy, Michael Clark, et al.. (1994). Bridged 1,2,5,6-tetrahydropyridine esters and oxime ethers related to arecoline are novel and potent muscarinic agonists. Bioorganic & Medicinal Chemistry Letters. 4(10). 1185–1190. 1 indexed citations
10.
Orlek, Barry S., et al.. (1994). Design and synthesis of novel muscarinic agonists containing the 1,2,4-triazine ring as an ester bioisostere. Bioorganic & Medicinal Chemistry Letters. 4(12). 1411–1414. 7 indexed citations
11.
Orlek, Barry S., et al.. (1993). Steric acceleration of intramolecular cycloaddition reactions. Tetrahedron. 49(36). 8179–8194. 18 indexed citations
12.
Bromidge, Steven M., et al.. (1993). A Convenient Synthesis of Masked β-Ketoaldehydes by the Controlled Addition of Nucleophiles to (Trimethylsilyl)ethynyl Ketones. Synthetic Communications. 23(4). 487–494. 16 indexed citations
13.
Orlek, Barry S.. (1993). A Short High Yielding Route to Methyl 2-(Quinuclidin-2-yl)acetate. Synlett. 1993(10). 758–758. 1 indexed citations
14.
Wadsworth, Harry J., S. M. Jenkins, Barry S. Orlek, et al.. (1992). Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives. Journal of Medicinal Chemistry. 35(7). 1280–1290. 68 indexed citations
15.
Bromidge, Steven M., Frank Brown, Frederick Cassidy, et al.. (1992). A novel and selective class of azabicyclic muscarinic agonists incorporating an N-methoxy imidoyl halide or nitrile functionality. Bioorganic & Medicinal Chemistry Letters. 2(8). 791–796. 16 indexed citations
16.
Bromidge, Steven M., Frank Brown, Frederick Cassidy, et al.. (1992). Design and synthesis of azabicyclic muscarinic agonists incorporating an oxime ether functionality. Bioorganic & Medicinal Chemistry Letters. 2(8). 787–790. 8 indexed citations
17.
Jenkins, S. M., Harry J. Wadsworth, Steven M. Bromidge, et al.. (1992). Substituent variation in azabicyclic triazole- and tetrazole-based muscarinic receptor ligands. Journal of Medicinal Chemistry. 35(13). 2392–2406. 61 indexed citations
18.
Orlek, Barry S., Frank E. Blaney, Frank Brown, et al.. (1991). Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor. Journal of Medicinal Chemistry. 34(9). 2726–2735. 171 indexed citations
19.
Orlek, Barry S. & Geoffrey Stemp. (1991). Stereoselective synthesis of protected amines and diamines from alkenes using N,N-Dichloro-t-butylcarbamate. Tetrahedron Letters. 32(32). 4045–4048. 30 indexed citations
20.
Knott-Hunziker, V, Barry S. Orlek, Peter G. Sammes, & S G Waley. (1980). Kinetics of inactivation of β-lactamase I by 6 β-bromopenicillanic acid. Biochemical Journal. 187(3). 797–802. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jordan Hirshfield Breakdown of academic impact, for papers by P. H. BENTLEY Breakdown of academic impact, for papers by Barton J. Bradbury Breakdown of academic impact, for papers by Gregory S. Welmaker Breakdown of academic impact, for papers by R. A. DAINES Breakdown of academic impact, for papers by Guo‐Hua Chu Breakdown of academic impact, for papers by Yushe Yang Breakdown of academic impact, for papers by John M. Berge Breakdown of academic impact, for papers by G. B. MULLEN Breakdown of academic impact, for papers by Troy Wymore
Rankless by CCL
2026